CD8A and neoplasm: Immunological analysis indicates that, compared with those tumours from the no-treatment group, tumour tissues isolated from mice treated with PEG2k-Fmoc-NLG(L) are more immunoactive with more functional CD4+ and CD8+ T cells, decreased Treg and MDSC, and increased M1/M2 ratios.